Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | SVP, Entertainment | October 01, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date October 01, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 166,803 |
Last balance in matching sequence
After 2026-10-01 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-10-01 · Exercise / conversion · Acquired 7,667 · Balance 174,470 F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Row 2 · 2026-10-01 · Sale · Disposed 6,831 · Balance 167,639 F2: The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Row 3 · 2026-10-01 · Sale · Disposed 836 · Balance 166,803 F3: The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.50 · Expires 2026-12-15 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-01 · Exercise / conversion · Disposed 7,667 · Balance 0 F4: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2: The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F4: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2024 Filed Feb 13, 2024 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 21,120 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0000950170-24-014128 · ownership.xml · derivative · entry 8 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 21,120 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. F5 · derivative.exercise_date: This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 21,120. shares. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,440 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0000950170-24-014128 · ownership.xml · derivative · entry 7 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 12,440 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. F4 · derivative.exercise_date: This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 33,560 | $80.81 | $2,711,896.34 |
DisclosureSEC source: 0000950170-24-014128 · ownership.xml · nonDerivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,519 F1 · kind: The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. F3 · price: The shares were sold in multiple transactions at prices ranging from $80.45 to $81.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 21,120 | $62.32 | $1,316,198.40 |
DisclosureSEC source: 0000950170-24-014128 · ownership.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. F2 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 12,440 | $42.98 | $534,671.20 |
DisclosureSEC source: 0000950170-24-014128 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. F2 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 21:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 21,120 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0000950170-24-013922 · ownership.xml · derivative · entry 8 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 21,120 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 21,120. shares. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 21:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,440 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0000950170-24-013922 · ownership.xml · derivative · entry 7 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 12,440 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 21:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 33,560 | $80.81 | $2,711,896.34 |
DisclosureSEC source: 0000950170-24-013922 · ownership.xml · nonDerivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,519 F2 · price: The shares were sold in multiple transactions at prices ranging from $80.45 to $81.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 21:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 21,120 | $62.32 | $1,316,198.40 |
DisclosureSEC source: 0000950170-24-013922 · ownership.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 21:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 12,440 | $42.98 | $534,671.20 |
DisclosureSEC source: 0000950170-24-013922 · ownership.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0000950170-24-014128 · ownership.xml · derivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,440 Underlying: Class A Common Stock · 50,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. F4 · derivative.exercise_date: This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 50,000 | $80.00 | $4,000,000.00 |
DisclosureSEC source: 0000950170-24-014128 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,519 F1 · kind: The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. F2 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 02:24 UTC Amendment | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 50,000 | $42.98 | $2,149,000.00 |
DisclosureSEC source: 0000950170-24-014128 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 158,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The original Form 4 did not report that option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2023. F2 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $42.98 | $0.00 |
DisclosureSEC source: 0000950170-24-013922 · ownership.xml · derivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,440 Underlying: Class A Common Stock · 50,000 shares Expires 2024-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 62,440 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 50,000 | $80.00 | $4,000,000.00 |
DisclosureSEC source: 0000950170-24-013922 · ownership.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,519 F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:45 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 50,000 | $42.98 | $2,149,000.00 |
DisclosureSEC source: 0000950170-24-013922 · ownership.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 158,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 00:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,488 | $87.49 | $130,185.12 |
DisclosureSEC source: 0001209191-23-059260 · doc4.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,519 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F6 · balance_after: Shares held following the reported transactions include 45,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 5,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059260 · doc4.xml · derivative · entry 7 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 5,427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F9 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,750 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,427 PSUs. The remaining 1,323 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. F9 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,750 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,427 PSUs. The remaining 1,323 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 30,327 | $0.00 Strike: $87.49 | $0.00 |
DisclosureSEC source: 0001209191-23-059260 · doc4.xml · derivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,327 Underlying: Class A Common Stock · 30,327 shares Expires 2033-12-15 F8 · derivative.exercise_date: This option was granted for a total of 30,327 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 8,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059260 · doc4.xml · derivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,651 Underlying: Class A Common Stock · 8,651 shares Expires not disclosed F7 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F7 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F7 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 9,093 | $88.60 | $805,639.80 |
DisclosureSEC source: 0001209191-23-059260 · doc4.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,007 F4 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F5 · balance_after: Shares held following the reported transactions include 48,029 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 5,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059260 · doc4.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F2 · balance_after: Shares held following the reported transactions include 60,939 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 00:34 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 17,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-059260 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,673 F1 · acquired: Award represents a total of 17,303 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2023. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2 · balance_after: Shares held following the reported transactions include 60,939 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 21:10 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 79 | $88.58 | $6,997.82 |
DisclosureSEC source: 0001209191-23-055721 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,370 F1 · balance_after: Shares held following the reported transaction include 43,636 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include (1) 87 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021, (2) 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022, and (3) 79 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2023. The shares acquired on November 15, 2021 and November 15, 2022 were not included in share totals reported previously due to administrative error. Read SEC document |
| May 15, 2023 Filed May 16, 2023 21:12 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 278 | $83.87 | $23,315.86 |
DisclosureSEC source: 0001209191-23-029860 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,245 F1 · balance_after: Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 278 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 21,850 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · derivative · entry 10 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 21,850 shares Expires 2023-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This performance-based stock option award was granted for a total of 23,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2019 was at 95% of target, or 21,850 shares. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,153 | $0.00 Strike: $37.35 | $0.00 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · derivative · entry 9 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,153 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 65,153 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 5,801 | $84.37 | $489,430.95 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · nonDerivative · entry 7 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,245 F5 · price: This transaction was executed in multiple trades at prices ranging from $84.26 to $84.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 31,202 | $83.86 | $2,616,646.52 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · nonDerivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,046 F4 · price: This transaction was executed in multiple trades at prices ranging from $83.26 to $84.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 21,850 | $45.50 | $994,175.00 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · nonDerivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 15,153 | $37.35 | $565,964.55 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $37.35 | $0.00 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · derivative · entry 8 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,153 Underlying: Class A Common Stock · 50,000 shares Expires 2023-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 65,153 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 8,262 | $85.24 | $704,252.88 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,245 F3 · price: The shares were sold in multiple transactions at prices ranging from $85.04 to $85.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 41,738 | $84.48 | $3,526,201.54 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,507 F2 · price: This transaction was executed in multiple trades at prices ranging from $84.03 to $85.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:24 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 50,000 | $37.35 | $1,867,500.00 |
DisclosureSEC source: 0001209191-23-007946 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 43,636 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 02:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,240 | $70.80 | $87,792.00 |
DisclosureSEC source: 0001209191-22-062076 · doc4.xml · nonDerivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,245 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F7 · balance_after: Shares held following the reported transactions include 43,636 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 02:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 4,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062076 · doc4.xml · derivative · entry 8 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,858 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F10 · derivative.exercise_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,000 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 4,858 PSUs. The remaining 1,142 PSUs were cancelled. F10 · derivative.expiration_date: The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,000 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 4,858 PSUs. The remaining 1,142 PSUs were cancelled. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 02:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 3,897 | $71.07 | $276,959.79 |
DisclosureSEC source: 0001209191-22-062076 · doc4.xml · nonDerivative · entry 4 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,485 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F6 · balance_after: Shares held following the reported transactions include 46,136 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 02:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 4,858 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-062076 · doc4.xml · nonDerivative · entry 3 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock. F4 · balance_after: Shares held following the reported transactions include 49,136 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 02:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 38,013 | $0.00 Strike: $71.07 | $0.00 |
DisclosureSEC source: 0001209191-22-062076 · doc4.xml · derivative · entry 7 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,013 Underlying: Class A Common Stock · 38,013 shares Expires 2031-12-15 F9 · derivative.exercise_date: This option was granted for a total of 38,013 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 02:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Restricted Stock Unit · Derivative | 10,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062076 · doc4.xml · derivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,557 Underlying: Class A Common Stock · 10,557 shares Expires not disclosed F8 · derivative.exercise_price: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F8 · derivative.exercise_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. F8 · derivative.expiration_date: The vesting of this performance-based restricted stock unit ("PSU") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 02:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 21,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-062076 · doc4.xml · nonDerivative · entry 2 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,524 F3 · acquired: Award represents a total of 21,114 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2022. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F4 · balance_after: Shares held following the reported transactions include 49,136 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 02:40 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 3,785 | $73.17 | $276,948.45 |
DisclosureSEC source: 0001209191-22-062076 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,410 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units. F2 · balance_after: Shares held following the reported transactions include 28,022 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 20:55 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 40 | $69.02 | $2,760.80 |
DisclosureSEC source: 0001209191-22-058595 · doc4.xml · nonDerivative · entry 1 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,195 F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. F2 · balance_after: Shares include 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,300 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · derivative · entry 10 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,300 shares Expires 2022-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 25,000 shares. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,300 | $67.72 | $291,201.59 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · nonDerivative · entry 7 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,235 F5 · price: This transaction was executed in multiple trades at prices ranging from $67.20 to $67.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 04, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 4,300 | $33.15 | $142,545.00 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · nonDerivative · entry 6 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,700 | $0.00 Strike: $33.15 | $0.00 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · derivative · entry 9 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,300 Underlying: Class A Common Stock · 20,700 shares Expires 2022-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This performance-based stock option award was granted for a total of 20,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2018 was at 125% of target, or 25,000 shares. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 29,300 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · derivative · entry 8 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 29,300 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was granted for a total of 49,300 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on each anniversary of December 21, 2012, the vesting commencement date. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 22:53 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 12,020 | $65.81 | $791,087.89 |
DisclosureSEC source: 0001209191-22-052892 · doc4.xml · nonDerivative · entry 5 Couling John D · CIK 0001894052 · SVP, Entertainment 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,235 F4 · price: This transaction was executed in multiple trades at prices ranging from $65.69 to $65.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.